ESC 365 - Cardiovascular outcome trials up to 2023: it's all about LDL-C lowering

Open Access

Cardiovascular outcome trials up to 2023: it's all about LDL-C lowering

Session: Latest advancements in low-density lipoprotein cholesterol (LDL-C) lowering therapies and cardiovascular outcome trials

Topic: Lipid-Lowering Agents

Speaker: Professor U. Laufs (Leipzig, DE)

Sponsored by Daiichi Sankyo

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Ulrich Laufs

University Hospital Leipzig, Leipzig (Germany)

40 presentations

2 followers

4 more presentations in this session

Setting the stage: LDL-C and cardiovascular risk

Speaker: Professor L. Tokgozoglu (Ankara, TR)

Data from 2023: it’s still all about LDL-C lowering

Speaker: Professor S. Nicholls (Melbourne, AU)

Panel discussion and Q&A

Speaker: Professor L. Tokgozoglu (Ankara, TR) Professor U. Laufs (Leipzig, DE) Professor S. Nicholls (Melbourne, AU)

Summary and meeting close

Speaker: Professor L. Tokgozoglu (Ankara, TR) Professor U. Laufs (Leipzig, DE) Professor S. Nicholls (Melbourne, AU)

Access the full session

Latest advancements in low-density lipoprotein cholesterol (LDL-C) lowering therapies and cardiovascular outcome trials

Speakers: Professor U. Laufs, Professor L. Tokgozoglu, Professor S. Nicholls, Professor L. Tokgozoglu, Professor U. Laufs...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources